{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T14:58:38Z","timestamp":1793717918195,"version":"4.6.1"},"reference-count":52,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cientifico e Tecnologico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Discovery Today"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.drudis.2022.04.004","type":"journal-article","created":{"date-parts":[[2022,4,7]],"date-time":"2022-04-07T11:54:01Z","timestamp":1649332441000},"page":"2278-2287","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":104,"title":["Approaches to advance drug discovery for neglected tropical diseases"],"prefix":"10.1016","volume":"27","author":[{"given":"Leonardo L.G.","family":"Ferreira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josu\u00e9","family":"de Moraes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriano D.","family":"Andricopulo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drudis.2022.04.004_b0005","doi-asserted-by":"crossref","first-page":"e0007999","DOI":"10.1371\/journal.pntd.0007999","article-title":"World neglected tropical diseases day","volume":"14","author":"Hotez","year":"2020","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.drudis.2022.04.004_b0010","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S1473-3099(19)30005-2","article-title":"Drugs and vaccines in the 21st century for neglected diseases","volume":"19","author":"Ferreira","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.drudis.2022.04.004_b0015","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1038\/d41586-021-02910-y","article-title":"Uneven attention hampers the drive to control infectious diseases","volume":"598","author":"DeWeerdt","year":"2021","journal-title":"Nature."},{"key":"10.1016\/j.drudis.2022.04.004_b0020","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1038\/d41586-021-02912-w","article-title":"Overlooked and underfunded: neglected diseases exert a toll","volume":"598","author":"Eisenstein","year":"2021","journal-title":"Nature."},{"key":"10.1016\/j.drudis.2022.04.004_b0025","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.pt.2020.04.005","article-title":"FDA-approved antiparasitic drugs in the 21st century: a success for helminthiasis?","volume":"36","author":"de Moraes","year":"2020","journal-title":"Trends Parasitol"},{"key":"10.1016\/j.drudis.2022.04.004_b0030","unstructured":"WHO. Ending the Neglect to attain the Sustainable Development Goals: A Road Map for Neglected Tropical Diseases 2021\u20132030. Geneva, WHO; 2021."},{"key":"10.1016\/j.drudis.2022.04.004_b0035","unstructured":"United Nations. The SDGs in Action, http:\/\/www.undp.org\/sustainable-development-goals [accessed April 1, 2022]."},{"key":"10.1016\/j.drudis.2022.04.004_b0040","unstructured":"Drugs for Neglected Diseases Initiative. LOLA: DNDi\u2019s First Innovative Neglected Disease Early-Stage Research Programme Launches in Latin America, http:\/\/www.dndi.org\/2013\/media-centre\/news-views-stories\/news\/first-early-stage-research-latin-america\/ [accessed April 1, 2022]."},{"key":"10.1016\/j.drudis.2022.04.004_b0045","unstructured":"Drugs for Neglected Diseases Initiative. NTD Drug Discovery Booster Hit-to-lead, https:\/\/dndi.org\/research-development\/portfolio\/drug-discovery-booster [accessed April 1, 2022]."},{"key":"10.1016\/j.drudis.2022.04.004_b0050","unstructured":"WIPO Re: Search. About WIPO Re: Search. http:\/\/www.wipo.int\/research\/en\/about\/ [accessed April 1, 2022]."},{"key":"10.1016\/j.drudis.2022.04.004_b0055","unstructured":"University of Dundee. http:\/\/www.dundee.ac.uk\/stories\/ps49million-wellcome-boost-drugs-research [accessed April 1, 2022]."},{"key":"10.1016\/j.drudis.2022.04.004_b0060","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1016\/j.drudis.2020.09.016","article-title":"Combining experimental strategies for successful target deconvolution","volume":"25","author":"Wilkinson","year":"2020","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.drudis.2022.04.004_b0065","doi-asserted-by":"crossref","first-page":"5755","DOI":"10.1038\/s41598-021-85225-2","article-title":"Identification of positive and negative regulators in the stepwise developmental progression towards infectivity in Trypanosoma brucei","volume":"11","author":"Toh","year":"2021","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.drudis.2022.04.004_b0070","doi-asserted-by":"crossref","first-page":"e0004659","DOI":"10.1371\/journal.pntd.0004659","article-title":"High throughput screening identifies novel lead compounds with activity against larval, juvenile and adult Schistosoma mansoni","volume":"10","author":"Mansour","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.drudis.2022.04.004_b0075","unstructured":"Medicines for Malaria Venture. The Pathogen Box. http:\/\/www.mmv.org\/mmv-open\/archived-projects\/pathogen-box [accessed April 1, 2022]."},{"key":"10.1016\/j.drudis.2022.04.004_b0080","unstructured":"Medicines for Malaria Venture. The Pandemic Response Box. http:\/\/www.mmv.org\/mmv-open\/pandemic-response-box [accessed April 1, 2022]."},{"key":"10.1016\/j.drudis.2022.04.004_b0085","doi-asserted-by":"crossref","first-page":"e00769","DOI":"10.1128\/mSphere.00769-20","article-title":"Trypanosoma brucei ORFeome-based gain-of-function library identifies genes that promote survival during melarsoprol treatment","volume":"5","author":"Carter","year":"2020","journal-title":"mSphere"},{"key":"10.1016\/j.drudis.2022.04.004_b0090","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.bbapap.2018.08.002","article-title":"Target deconvolution from phenotype-based drug discovery by using chemical proteomics approaches","volume":"1867","author":"Kubota","year":"2019","journal-title":"Biochim Biophys Acta Proteins Proteom"},{"key":"10.1016\/j.drudis.2022.04.004_b0095","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1021\/acsinfecdis.8b00226","article-title":"Pharmacological validation of N-myristoyltransferase as a drug target in Leishmania donovani","volume":"5","author":"Corpas-Lopez","year":"2019","journal-title":"ACS Infect Dis"},{"key":"10.1016\/j.drudis.2022.04.004_b0100","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/s41467-020-14484-w","article-title":"In cellulo crystallization of Trypanosoma brucei IMP dehydrogenase enables the identification of genuine co-factors","volume":"11","author":"Nass","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.drudis.2022.04.004_b0105","doi-asserted-by":"crossref","first-page":"10362","DOI":"10.1021\/acs.jmedchem.9b01429","article-title":"Chagas disease drug discovery: multiparametric lead optimization against Trypanosoma cruzi in acylaminobenzothiazole series","volume":"62","author":"Fleau","year":"2019","journal-title":"J Med Chem"},{"key":"10.1016\/j.drudis.2022.04.004_b0110","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/j.drudis.2019.03.015","article-title":"ADMET modeling approaches in drug discovery","volume":"24","author":"Ferreira","year":"2019","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.drudis.2022.04.004_b0115","doi-asserted-by":"crossref","first-page":"3485","DOI":"10.1021\/acs.jmedchem.9b00985","article-title":"Lead optimization of phthalazinone phosphodiesterase inhibitors as novel antitrypanosomal compounds","volume":"63","author":"Salado","year":"2020","journal-title":"J Med Chem"},{"key":"10.1016\/j.drudis.2022.04.004_b0120","doi-asserted-by":"crossref","first-page":"116016","DOI":"10.1016\/j.bmc.2021.116016","article-title":"Antileishmanial macrolides from ant-associated Streptomyces sp. ISID311","volume":"32","author":"Ortega","year":"2021","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.drudis.2022.04.004_b0125","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/s41573-020-00114-z","article-title":"International Natural Product Sciences Taskforce, Supuran CT. Natural products in drug discovery: advances and opportunities","volume":"20","author":"Atanasov","year":"2021","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.drudis.2022.04.004_b0130","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1039\/D0MD00353K","article-title":"Collaborative virtual screening to elaborate an imidazo[1,2-a]pyridine hit series for visceral leishmaniasis","volume":"12","author":"Akao","year":"2021","journal-title":"RSC Med Chem"},{"key":"10.1016\/j.drudis.2022.04.004_b0135","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.chembiol.2021.02.008","article-title":"Multiple unbiased approaches identify oxidosqualene cyclase as the molecular target of a promising anti-leishmanial","volume":"28","author":"Paradela","year":"2021","journal-title":"Cell Chem Biol"},{"key":"10.1016\/j.drudis.2022.04.004_b0140","doi-asserted-by":"crossref","first-page":"61","DOI":"10.4155\/fmc-2016-0180","article-title":"Polyamine-trypanothione pathway: an update","volume":"9","author":"Ilari","year":"2017","journal-title":"Future Med Chem"},{"key":"10.1016\/j.drudis.2022.04.004_b0145","doi-asserted-by":"crossref","first-page":"15621","DOI":"10.1021\/acs.jmedchem.0c00690","article-title":"Targeting the trypanothione reductase of tissue-residing Leishmania in hosts\u2019 reticuloendothelial system: a flexible water-soluble ferrocenylquinoline-based preclinical drug candidate","volume":"63","author":"Mukherjee","year":"2020","journal-title":"J Med Chem"},{"key":"10.1016\/j.drudis.2022.04.004_b0150","doi-asserted-by":"crossref","first-page":"e0009196","DOI":"10.1371\/journal.pntd.0009196","article-title":"2-aminobenzimidazoles for leishmaniasis: from initial hit discovery to in vivo profiling","volume":"15","author":"Ferreira","year":"2021","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.drudis.2022.04.004_b0155","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1021\/acs.jcim.9b00802","article-title":"Discovery of potent, reversible, and competitive cruzain inhibitors with trypanocidal activity: a structure-based drug design approach","volume":"60","author":"de Souza","year":"2020","journal-title":"J Chem Inf Model"},{"key":"10.1016\/j.drudis.2022.04.004_b0160","doi-asserted-by":"crossref","first-page":"774069","DOI":"10.3389\/fphar.2021.774069","article-title":"Multiparameter optimization of trypanocidal cruzain inhibitors with in vivo activity and favorable pharmacokinetics","volume":"12","author":"Pauli","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.drudis.2022.04.004_b0165","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1021\/jm401709b","article-title":"Synthesis, biological evaluation, and structure-activity relationships of potent noncovalent and nonpeptidic cruzain inhibitors as anti-Trypanosoma cruzi agents","volume":"57","author":"Ferreira","year":"2014","journal-title":"J Med Chem"},{"key":"10.1016\/j.drudis.2022.04.004_b0170","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1021\/acsinfecdis.9b00426","article-title":"The Qi site of cytochrome b is a promiscuous drug target in Trypanosoma cruzi and Leishmania donovani","volume":"6","author":"Wall","year":"2020","journal-title":"ACS Infect Dis"},{"key":"10.1016\/j.drudis.2022.04.004_b0175","doi-asserted-by":"crossref","first-page":"e0073821","DOI":"10.1128\/Spectrum.00738-21","article-title":"Drug target validation of the protein kinase AEK1, essential for proliferation, host cell invasion, and intracellular replication of the human pathogen Trypanosoma cruzi","volume":"9","author":"Chiurillo","year":"2021","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.drudis.2022.04.004_b0180","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1038\/s41467-021-21273-6","article-title":"Fast acting allosteric phosphofructokinase inhibitors block trypanosome glycolysis and cure acute African trypanosomiasis in mice","volume":"12","author":"McNae","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.drudis.2022.04.004_b0185","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1038\/s41564-020-0745-6","article-title":"Targeting the trypanosome kinetochore with CLK1 protein kinase inhibitors","volume":"5","author":"Saldivia","year":"2020","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.drudis.2022.04.004_b0190","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1042\/BST20190517","article-title":"Glycosome heterogeneity in kinetoplastids","volume":"49","author":"Crowe","year":"2021","journal-title":"Biochem Soc Trans."},{"key":"10.1016\/j.drudis.2022.04.004_b0195","doi-asserted-by":"crossref","first-page":"703603","DOI":"10.3389\/fcell.2021.703603","article-title":"A small molecule inhibitor of Pex3\u2013Pex19 interaction disrupts glycosome biogenesis and causes lethality in Trypanosoma brucei","volume":"9","author":"Banerjee","year":"2021","journal-title":"Front Cell Dev Biol."},{"key":"10.1016\/j.drudis.2022.04.004_b0200","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1096\/fj.06-6818com","article-title":"The Trypanosoma brucei cAMP phosphodiesterases TbrPDEB1 and TbrPDEB2: flagellar enzymes that are essential for parasite virulence","volume":"21","author":"Oberholzer","year":"2007","journal-title":"FASEB J"},{"key":"10.1016\/j.drudis.2022.04.004_b0205","doi-asserted-by":"crossref","first-page":"608030","DOI":"10.3389\/fchem.2020.608030","article-title":"Discovery of diaryl ether substituted tetrahydrophthalazinones as TbrPDEB1 inhibitors following structure-based virtual screening","volume":"8","author":"de Heuvel","year":"2021","journal-title":"Front Chem."},{"key":"10.1016\/j.drudis.2022.04.004_b0210","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ijpddr.2020.05.002","article-title":"Identification of annotated bioactive molecules that impair motility of the blood fluke Schistosoma mansoni","volume":"13","author":"Duguet","year":"2020","journal-title":"Int J Parasitol Drugs Drug Resist"},{"issue":"1","key":"10.1016\/j.drudis.2022.04.004_b0215","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1186\/s13071-020-04140-z","article-title":"H1-antihistamines as antischistosomal drugs: in vitro and in vivo studies","volume":"13","author":"Xavier","year":"2020","journal-title":"Parasit Vectors"},{"issue":"7","key":"10.1016\/j.drudis.2022.04.004_b0220","doi-asserted-by":"crossref","first-page":"686","DOI":"10.3390\/ph14070686","article-title":"Antiparasitic properties of cardiovascular agents against human intravascular parasite Schistosoma mansoni","volume":"14","author":"Porto","year":"2021","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.drudis.2022.04.004_b0225","doi-asserted-by":"crossref","first-page":"113823","DOI":"10.1016\/j.ejmech.2021.113823","article-title":"Anti-schistosomal activities of quinoxaline-containing compounds: from hit identification to lead optimisation","volume":"226","author":"Padalino","year":"2021","journal-title":"Eur J Med Chem."},{"issue":"3","key":"10.1016\/j.drudis.2022.04.004_b0230","doi-asserted-by":"crossref","first-page":"e01370","DOI":"10.1128\/AAC.01370-20","article-title":"Activities of quinoxaline, nitroquinoxaline, and [1,2,4]triazolo[4,3-a]quinoxaline analogs of MMV007204 against Schistosoma mansoni","volume":"65","author":"Debbert","year":"2021","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.drudis.2022.04.004_b0235","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1021\/acsinfecdis.9b00224","article-title":"Screening and phenotypical characterization of Schistosoma mansoni histone deacetylase 8 (SmHDAC8) inhibitors as multistage antischistosomal agents","volume":"6","author":"Saccoccia","year":"2020","journal-title":"ACS Infect Dis"},{"key":"10.1016\/j.drudis.2022.04.004_b0240","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s13071-020-4000-z","article-title":"The antischistosomal potential of GSK-J4, an H3K27 demethylase inhibitor: insights from molecular modeling, transcriptomics and in vitro assays","volume":"13","author":"Lobo-Silva","year":"2020","journal-title":"Parasit Vectors"},{"key":"10.1016\/j.drudis.2022.04.004_b0245","doi-asserted-by":"crossref","first-page":"945","DOI":"10.4155\/fmc-2020-0311","article-title":"New evidence for tamoxifen as an antischistosomal agent: in vitro, in vivo and target fishing studies","volume":"13","author":"Silva","year":"2021","journal-title":"Future Med Chem"},{"key":"10.1016\/j.drudis.2022.04.004_b0250","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1126\/science.abb7699","article-title":"Large-scale RNAi screening uncovers therapeutic targets in the parasite Schistosoma mansoni","volume":"369","author":"Wang","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.drudis.2022.04.004_b0255","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/s42003-020-01402-5","article-title":"A multi-dimensional, time-lapse, high content screening platform applied to schistosomiasis drug discovery","volume":"3","author":"Chen","year":"2020","journal-title":"Commun Biol"},{"issue":"11","key":"10.1016\/j.drudis.2022.04.004_b0260","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/nrd4683","article-title":"Hit and lead criteria in drug discovery for infectious diseases of the developing world","volume":"14","author":"Katsuno","year":"2015","journal-title":"Nat Rev Drug Discov"}],"container-title":["Drug Discovery Today"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644622001350?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644622001350?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T12:58:42Z","timestamp":1761224322000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1359644622001350"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":52,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["S1359644622001350"],"URL":"https:\/\/doi.org\/10.1016\/j.drudis.2022.04.004","relation":{},"ISSN":["1359-6446"],"issn-type":[{"value":"1359-6446","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Approaches to advance drug discovery for neglected tropical diseases","name":"articletitle","label":"Article Title"},{"value":"Drug Discovery Today","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drudis.2022.04.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}